¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"toxic bullous epidermolysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bullous keratopathy
    ¹°Áý°¢¸·º´(Áõ), ¼öÆ÷°¢¸·º´(Áõ)
  • bullous mastocytosis
    ¹°Áýºñ¸¸¼¼Æ÷Áõ
  • bullous pemphigoid
    ¹°ÁýÀ¯»çõÆ÷â, ¹°ÁýÀ¯»ç¹°ÁýÁõ
  • bullous systemic lupus erythematosus
    ¹°ÁýÀü½ÅÈ«¹Ý·çǪ½º
  • congenital bullous icthyosiform erythroderma
    ¼±Ãµ¹°Áýºñ´ÃÁõ¸ð¾çÈ«»öÇǺÎ(Áõ), ¼±Ãµ¼öÆ÷ºñ´ÃÁõ¸ð¾çÈ«»öÇǺÎ(Áõ)
  • pseudophakic bullous keratopathy
    Àΰø¼öÁ¤Ã¼¹°Áý°¢¸·º´(Áõ), Àΰø¼öÁ¤Ã¼¼öÆ÷°¢¸·º´(Áõ)
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bullous follicular keratosis
    ¼öÆ÷¸ð³¶°¢È­Áõ, ¹°ÁýÅÐÁý°¢È­Áõ
  • bullous systemic l. erythematosusv lupus
    ¹°ÁýÀü½ÅÈ«¹Ý·çÇÁ½º
  • congenital bullous icthyosiform erythroderma
    ¼±Ãµ¹°Áýºñ´ÃÇǺÎÁõ¸ð¾çÈ«»öÇǺÎÁõ
  • pseudophakic bullous keratopathy
    Àΰø¼öÁ¤Ã¼¹°Áý°¢¸·º´Áõ
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic alopecia
    µ¶¼ºÅ»¸ðÁõ
  • toxic amaurosis
    Áßµ¶Èæ¾Ï½Ã
  • toxic amblyopia
    µ¶¼º¾à½Ã
  • toxic atrophy
    Áßµ¶À§Ãà
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • toxic cardiopathy
    Áßµ¶½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå
  • toxic conjunctivitis
    µ¶¼º°á¸·¿°
  • toxic convulsion
    Áßµ¶°æ·Ã
  • toxic liver cirrhosis
    µ¶¼º°£°æÈ­(Áõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • epidermolysis bullosa<³ª>
    ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • generalized autosomal recessive dystrophic epidermolysis bullosa
    Àü½Å¼º »ó¿°»öü ¿­¼º ÀÌ¿µ¾ç¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • generalized nonmutilating ausomal recessive dystrophic epidermolysis b
    Àü½Å¼º ºñÀý´Ü¼º »ó¿°»öü ¿­¼º ÀÌ¿µ¾ç¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • hyperplastic epidermolysis bullosa
    °úÇü¼º ¼öÆ÷¼º Ç¥Çǹڸ®Áõ
  • junctional epidermolysis bullosa
    ¿¬Á¢ºÎ¼öÆ÷¼ºÇ¥Çǹڸ®Áõ
  • recessive dystrophic epidermolysis bullosa
    ¿­¼º ¿µ¾çÀå¾Ö ¼öÆ÷ Ç¥Çǹڸ®Áõ
  • simple epidermolysis ³ª e. simplex
    ´Ü¼øÇ¥Çǹڸ®Áõ(¡­øúù«ÚÎìÆñø)
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼¼öÆ÷°¢¸·º´Áõ
  • blistering(bullous) disease
    ¼öÆ÷¼ºÁúȯ(¡­òðü´)
  • bullous
    ¼öÆ÷¼ºÀÇ
  • bullous congenital icthyosiform erythroderma
    ¼öÆ÷¼º ¼±Ãµ¼º ¾î¸°¼±»ó È«ÇÇÁõ
  • bullous dermatitis
    ¼öÆ÷¼º ÇǺο°
  • bullous dermatosis
    ¼öÆ÷¼º ÇǺκ´(Áõ)
  • bullous dermatosis
    ¼öÆ÷¼º ÇǺκ´(Áõ)(¡­ù«Ý±Ü»)
  • bullous dermatosis,linear iga
    ¼±»ó IgA (àÊß¾¡­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BIE bullous ichthyosiform erythroderma
BP Bachelor of Pharmacy; back pressure; barometric pressure; basic protein; bathroom privileges; bed pa...
BPAG bullous pemphigoid antigen
CBDC chronic bullous disease of children
DEB diepoxybutane; diethylbutanediol; Division of Environmental Biology; dystrophic epidermolysis bullos...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CBDC Chronic bullous disease of childhood
DEB Dystrophic Epidermolysis Bullosa
EB Epidermolysis Bullosa
EBS Epidermolysis Bullosa Simplex
EBA Epidermolysis bullosa acquisita
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • toxic mucosal damage
    µ¶¼º Á¡¸· ¼Õ»ó
  • toxic myocarditis
    Áßµ¶¼º ½É±Ù¿°
  • toxic reaction
    µ¶ ¹ÝÀÀ, Áßµ¶ ¹ÝÀÀ
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • toxic uninodular goiter
    Áßµ¶¼º ´Ü°áÀý¼º °©»ó¼±Á¾
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼ ¼öÆ÷ °¢¸·º´Áõ
  • bullous
    ¼öÆ÷Çü, ¼öÆ÷¼º, Å« ¼öÆ÷¼º
    ¼öÆ÷¿¡ °üÇÑ °ÍÀ̳ª ¼öÆ÷°¡ Ư¡ÀÎ.
  • bullous congenital icthyosiform erythroderma
    ¼öÆ÷¼º ¼±Ãµ¼º ¾î¸°¼±»ó È«ÇÇÁõ
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • bullous drug-induced exanthema
    ¾à¹°¿¡ ÀÇÇÑ ¼öÆ÷¼º ¹ßÁø
  • bullous lesion
    ¼öÆ÷¼º º´¼Ò
  • bullous pemphigoid
    ¼öÆ÷¼º À¯ÃµÆ÷â
    1. ÇǺγª Á¡¸·ÀÇ ±âÀú¸·´ë¿¡ ´ëÇÑ Ig G, IgE ÇüÀÇ ÀÚ°¡ Ç×ü¸¦ °¡Áö´Â ÀÚ°¡ ¸é¿ª Áúȯ. 2. »óÇÇ ±âÀú¸·ÀÇ Åõ¸íÆÇ³»¿¡ ÀÖ´Â 220Kd ´Ü¹éÁú¿¡ ´ëÇÑ ÀÚ°¡ Ç×ü°¡ Ư¡. ÀÓ»óÀûÀ¸·Î 50´ë À̻󿡼­ Á¦ÀÏ ¸ÕÀú ¹ß°ßµÇ¸ç ³²ÀÚ°¡ ¿©ÀÚº¸´Ù ¸¹ÀÌ ¹ß»ýÇϰí ÇǺΰ¡ Á¦ÀÏ ¸ÕÀú ¹ß»ýÇÏ´Â ºÎÀ§ÀÌ´Ù. ±¸°­ º´¼Ò´Â º°·Î ³ªÅ¸³ªÁö ¾ÊÀ¸¸ç ³Ð°Ô ºÐÆ÷ÇÑ´Ù. Ãʱâ Ä¡·á´Â ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÇ ±¹¼ÒµµÆ÷ÀÌ´Ù.
  • bullous skin disease
    ¼öÆ÷¼º ÇǺΠÁúȯ
  • bullous-erosive
    ¼öÆ÷-¹Ì¶õ¼º
  • bullous-erosive lesion
    ¼öÆ÷-¹Ì¶õ¼º º´¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
bullous oedema A reddened, swollen appearance of the ureteral orifice in the bladder wall, frequently observed with distal ureteral calculi or in tuberculosis of the ureter.
(05 Mar 2000)
bullous oedema vesicae A prominent area of focal oedema involving the bladder mucosa, consisting of elevated masses of edematous tissue or clusters of clear fluid-filled vesicles; often associated with chronic inflammation or irritation secondary to tubes, foreign bodies, or perivesical inflammation.
(05 Mar 2000)
bullous pemphigoid <dermatology> Form of pemphigoid (which also affects mucous membranes), in which blisters (bulli) form on the skin. Patients have circulating antibody (usually IgG) to basement membrane of stratified epithelium although the antibody titre does not correlate with the severity of the disease.
(18 Nov 1997)
bullous pemphiguoid A disease characterised by tense blistering eruptions of the skin. Caused by antibodies abnormally accumulating in a layer of the skin called the basement membrane. Can be chronic and mild without affecting the general health. It is diagnosed by skin biopsy showing the abnormal antibodies deposited in the skin layer. Treatment is with topical cortisone creams, but sometimes requires high doses of cortisone ( steroids ) taken internally.
(12 Dec 1998)
bullous syphilid A rare manifestation of congenital syphilis.
Synonym: pemphigoid syphilid.
(05 Mar 2000)
pemphigoid, bullous A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
(12 Dec 1998)
chronic bullous dermatosis of childhood A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin.
Synonym: linear IgA bullous disease in children.
(05 Mar 2000)
dermolytic bullous dermatosis Form of epidermolysis bullosa characterised by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms.
(12 Dec 1998)
linear IgA bullous disease in children A rare self-limiting bullous disease, chiefly of the trunk, perioral, and pelvic areas, with onset in the first decade, successively less severe recurrences, and total remission at adolescence; linear epidermal basement membrane zone deposit of IgA is found in involved and in normal skin.
Synonym: linear IgA bullous disease in children.
(05 Mar 2000)
megacolon, toxic Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon.
(12 Dec 1998)
goiter, diffuse toxic Graves' disease, the most common cause of hyperthroidism, too much thyroid hormone.
(12 Dec 1998)
goiter, toxic multinodular Condition in which the thyroid gland contains multiple lumps (nodules) that are overactive and produce excess thyroid hormones. This condition is also known as Parry's disease or Plummer's disease.
(12 Dec 1998)
plants, toxic Plants or plant parts which are harmful to man or other animals.
(12 Dec 1998)
hepatitis, toxic Acute hepatitis caused by true hepatotoxins such as amanita phaloides toxin, carbon tetrachloride, yellow phosphorus, and a variety of drugs.
(12 Dec 1998)
shock, toxic See Syndrome, toxic shock.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á